Prevention of CaCl2-induced aortic inflammation and subsequent aneurysm formation by the CCL3-CCR5 axis.
Yuko IshidaYumi KuninakaMizuho NosakaAkihiko KimuraAkira TaruyaMachi FurutaNaofumi MukaidaToshikazu KondoPublished in: Nature communications (2020)
Inflammatory mediators such as cytokines and chemokines are crucially involved in the development of abdominal aortic aneurysm (AAA). Here we report that CaCl2 application into abdominal aorta induces AAA with intra-aortic infiltration of macrophages as well as enhanced expression of chemokine (C-C motif) ligand 3 (CCL3) and MMP-9. Moreover, infiltrating macrophages express C-C chemokine receptor 5 (CCR5, a specific receptor for CCL3) and MMP-9. Both Ccl3-/- mice and Ccr5-/- but not Ccr1-/- mice exhibit exaggerated CaCl2-inducced AAA with augmented macrophage infiltration and MMP-9 expression. Similar observations are also obtained on an angiotensin II-induced AAA model. Immunoneutralization of CCL3 mimics the phenotypes observed in CaCl2-treated Ccl3-/- mice. On the contrary, CCL3 treatment attenuates CaCl2-induced AAA in both wild-type and Ccl3-/- mice. Consistently, we find that the CCL3-CCR5 axis suppresses PMA-induced enhancement of MMP-9 expression in macrophages. Thus, CCL3 can be effective to prevent the development of CaCl2-induced AAA by suppressing MMP-9 expression.
Keyphrases
- liver injury
- drug induced
- liver fibrosis
- poor prognosis
- high glucose
- diabetic rats
- angiotensin ii
- wild type
- dendritic cells
- oxidative stress
- abdominal aortic aneurysm
- regulatory t cells
- aortic valve
- heart failure
- type diabetes
- cell migration
- binding protein
- immune response
- left ventricular
- insulin resistance
- long non coding rna
- vascular smooth muscle cells
- smoking cessation
- angiotensin converting enzyme